Prevalence of Carbapenem-Resistant Enterobacterales in a Tertiary Care Hospital
International Journal of Pharmaceutical Quality Assurance · 10.07.2026 · 16 (11)
DOI: 10.25258/ijpqa.16.11.75 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 10.07.2026. Verfasst von Kumari Ritu und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Carbapenem-resistant Enterobacterales (CRE) pose a serious threat to patient safety in tertiary care hospitals, limiting treatment options and increasing morbidity and mortality.
Aim
To evaluate the prevalence, species distribution, and carbapenem resistance patterns among Enterobacterales isolated from clinical specimens in a tertiary care hospital. Methodology: An observational laboratory-based study was conducted over a period of seven months at Patna Medical College and Hospital, Patna, Bihar, India. A total of eighty non-duplicate carbapenem-resistant Enterobacterales isolates obtained from hospitalized patients were included. Identification and antimicrobial susceptibility testing were performed using standard microbiological methods in accordance with Clinical and Laboratory Standards Institute (CLSI) 2025 guidelines. Data were analyzed using SPSS version 27.0.
Results
CRE infections were most commonly observed among patients aged 41–60 years (40%) and in males (60%). Blood (27.5%) and respiratory samples (22.5%) were the predominant sources of isolates. Klebsiella pneumoniae (42.5%) was the most frequently isolated organism, followed by Escherichia coli (32.5%). High resistance rates were observed against ertapenem (82.5%), imipenem (77.5%), meropenem (72.5%), and doripenem (67.5%). The highest proportion of isolates was reported from the intensive care unit (37.5%).
Conclusion
The high burden of carbapenem-resistant Enterobacterales, particularly in critical care settings, highlights the need for continuous surveillance, strict infection control practices, and effective antimicrobial stewardship programs.
Zitieren
APA
Ritu, K., Narain, T., Nandan, P., & Kumar, V. (2026). Prevalence of Carbapenem-Resistant Enterobacterales in a Tertiary Care Hospital. International Journal of Pharmaceutical Quality Assurance, 16(11). https://doi.org/10.25258/ijpqa.16.11.75
Vancouver
Ritu K, Narain T, Nandan P, Kumar V. Prevalence of Carbapenem-Resistant Enterobacterales in a Tertiary Care Hospital. International Journal of Pharmaceutical Quality Assurance. 2026;16(11). doi:10.25258/ijpqa.16.11.75
BibTeX
@article{Ritu2026,
author = {Ritu, Kumari and Narain, Tanushree and Nandan, Pratulya and Kumar, Vijay},
title = {Prevalence of Carbapenem-Resistant Enterobacterales in a Tertiary Care Hospital},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {11},
doi = {10.25258/ijpqa.16.11.75}
}
EUVIMED